QUOTE AND NEWS
newratings.com  Sep 20  Comment 
WASHINGTON (dpa-AFX) - Shares of NovaBay Pharmaceuticals Inc. (NBY) rose more than 8% on Monday after the company announced that Auriclosene Irrigating Solution demonstrated statistically significant and clinically meaningful results in a phase 2b...
FierceBiotech  Sep 19  Comment 
Another Vical vax flop, this time with Astellas-partnered CMV vaccine badams Mon, 09/19/2016 - 07:18
Benzinga  Jul 19  Comment 
  Analysts at Barclays initiated coverage of MPLX LP (NYSE: MPLX) with an Overweight rating. The price target for MPLX is set to $42. MPLX shares fell 0.96 percent to close at $33.00 on Monday. Analysts at Summit Redstone assumed ...





You may also be interested in articles related to Vical (VICL):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki